Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Completed × Gastrointestinal Neoplasms × Palonosetron × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Vomiting 23 Nausea 14 Neoplasms 11 Breast Neoplasms 4 Multiple Myeloma 2 Lymphoma 2 Breast Neoplasms, Male 2 Weight Loss 1 Solid Tumors 1 Sarcoma 1 Rectal Neoplasms 1 Nausea With Vomiting Chemotherapy-Induced 1 Melanoma 1 Leukemia 1 Inflammatory Breast Neoplasms 1 Hematologic Neoplasms 1 Glioma 1 Genital Neoplasms, Female 1 Gastrointestinal Neoplasms 1 Colorectal Neoplasms 1 Colonic Neoplasms 1 Anorexia 1

Interventions

Oxaliplatin 11 Fluorouracil 10 Surveys and Questionnaires 8 Leucovorin 8 Cisplatin 8 Capecitabine 8 Irinotecan 7 Bevacizumab 6 Standard of Care 5 Gemcitabine 5 Drug Therapy 4 S 1 (combination) 3 Radiotherapy 3 Interviews as Topic 3 Educational Status 3 Cyclophosphamide 3 trebananib 2 tivozanib 2 pembrolizumab 2 Taxes 2 Remote Patient Monitoring 2 Pemetrexed 2 Panitumumab 2 Ocoxin 2 Nivolumab 2 N-(2-fluoro-4-((2-(4-(4-methylpiperazin-1-yl)piperidin-1-yl)carbonylaminopyridin-4-yl)oxy)phenyl)-N'-(4-fluorophenyl)cyclopropane-1,1-dicarboxamide 2 Mitomycin 2 Mass Screening 2 MLN 8237 2 Interleukin-2 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT03674294 2023-02-08

CINV

Sun Yat-sen University

Phase 3 Completed

Gastrointestinal

Gastrointestinal Neoplasms, Vomiting

Data powered by HemOnc (CC BY 4.0) Colophon ⚡